Ikerian
software solutions to accelerate clinical, research, and pharmaceutical workflows using advanced machine learning and computer vision
Ikerian has raised €5.8M across 1 funding round from 5 investors, most recently a Series A round in May 2024. Based in Bern, Switzerland; active in Software. Data as of 28 Oct 2026.
Total raised
€5.8M
€5,776,781
Funding rounds
1
Investors
5
distinct backers
Active since
2024-05
latest 2024-05
Funding by year
EUR raised per yearIkerian — funding by year — interactive chart.
Data table
| Ikerian — funding by year | |
|---|---|
| 2024 | €5.8M |
Signals
High confidenceRaise-next likelihood31
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-05-02 | Series A | €5.8M | btov Industrial Technologies Fund,Private Investors,Topcon Healthcare,Verve Ventures,Zürcher Kantonalbank | View deal → |
Investors
5Related news
Similar companies
same sector or country- DAZN€3.8BUK · Software
- Visma€3.0BNorway · Software
- Celonis€2.2BGermany · Software
- Bending Spoons€1.7BItaly · Software
- UiPath€1.7BRomania · AI
- ContentSquare€1.3BFrance · Software
Global coverage: FundingData